WuXi BioInnovate
Luncheon Series
.png)
Concept
Join Us!
Join us for the WuXi BioInnovate Luncheon Series at Biologics Manufacturing Asia 2026, where industry leaders come together for a dynamic and interactive discussion on overcoming the toughest challenges in biologics manufacturing. This exclusive session is designed to explore how WuXi Biologics collaborates with partners to navigate complexities at every stage of production, setting the benchmark for a successful CDMO-client partnership. Engage with industry experts, gain fresh insights from real-world case studies, and participate in expert-led panel discussions that tackle practical problems head-on. This is more than just a luncheon—it’s a platform for idea exchange, problem-solving, and driving the future of biologics manufacturing forward.
.webp)
Highlights
- Gain valuable insights and explore practical applications through scientific talks.
- Explore cutting-edge solutions at our product demonstrations and exhibition.
- Connect & engage with industry experts and peers to discuss innovative strategies for utilizing Sartorius' solutions.
Sessions
Agenda
Facilitator :
Sherry Gu, EVP & Chief Technology Officer, WuXi Biologics
Facilitator :
Chris Lee, Head of Singapore Biologics Development and Manufacturing, WuXi Biologics
Facilitator :
Jun Hu, VP, Head of XDC CEC and Singapore Site Management, WuXi XDC
Facilitator :
Sherry Gu, EVP & Chief Technology Officer, WuXi Biologics
Chris Lee, Head of Singapore Biologics Development and Manufacturing, WuXi Biologics
Jun Hu, VP, Head of XDC CEC and Singapore Site Management, WuXi XDC
Hui Cai, SVP, Head of the Global Manufacturing Department (US and APAC), WuXi Biologics
Jeremy Guo, SVP, Head of Global Drug Product Operations Department, WuXi Biologics
Facilitator :
Shine Huang, Head of Global Marketing, WuXi Biologics
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Dr. Jun Hu is currently Head of Client Enabling Center of Excellence and Singapore Site Management at WuXi XDC, by leading a diversified team of talents, including PMs and BDs to help enable global partners’ success on various bioconjugate programs. He is currently leading a team to support construct and manage new manufacturing site at Tuas Singapore. He has nearly 15 years’ comprehensive experience in process development, GMP manufacturing, CMC management, business development, operational excellence as well as team management. Dr. Hu obtained his Ph.D. degree in Bioengineering from Tokyo Institute of Technology, and bachelor’s degree in chemical engineering from Tsinghua University. Before he joined WuXi Biologics/WuXi XDC he was working in Takeda Pharmaceutical Company Japan on process development and clinical GMP manufacturing.
Hui Cai is the Senior Vice President, Head of the Global Manufacturing (US and APAC) Department at WuXi Biologics. She manages the company's Drug Substance clinical manufacturing sites in China, the manufacturing sites in the United States, and WuXi Biologics' Singapore facility. Prior to joining WuXi Biologics, Dr. Hui Cai worked at PPD (now Thermo Fisher) and Bristol-Myers Squibb in the United States, supporting process development, pilot plant, clinical and commercial production, etc. She has accumulated rich biologics experience in analytics, microbial contamination & control, protein manufacturing, technology transfer, and CMC management. Dr. Cai received her Ph.D. degree from the University of Wisconsin-Madison.
